Related Experiment Video
Updated: May 8, 2026

Interview: Glycolipid Antigen Presentation by CD1d and the Therapeutic Potential of NKT cell Activation
Published on: December 31, 2007
Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection
Sandrine Aspeslagh1, Marek Nemčovič2, Nora Pauwels3
1Laboratory for Molecular Immunology and Inflammation, Department of Rheumatology, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
Abstract:
NKT cells, a unique type of regulatory T cells, respond to structurally diverse glycolipids presented by CD1d. Although it was previously thought that recognition of glycolipids such as α-galactosylceramide (α-GalCer) by the NKT cell TCR (NKTCR) obeys a key-lock principle, it is now clear this interaction is much more flexible. In this article, we report the structure-function analysis of a series of novel 6''-OH analogs of α-GalCer with more potent antitumor characteristics. Surprisingly, one of the novel carbamate analogs, α-GalCer-6''-(pyridin-4-yl)carbamate, formed novel interactions with the NKTCR. This interaction was associated with an extremely high level of Th1 polarization and superior antitumor responses. These data highlight the in vivo relevance of adding aromatic moieties to the 6''-OH position of the sugar and additionally show that judiciously chosen linkers are a promising strategy to generate strong Th1-polarizing glycolipids through increased binding either to CD1d or to NKTCR.
Insights
Researchers explored novel glycolipids to enhance NKT cell therapy. A new analog showed potent antitumor activity by forming unique interactions with the NKT cell receptor, boosting immune response.
Area of Science:
- Immunology
- Biochemistry
Background:
- Natural Killer T (NKT) cells are regulatory T cells that recognize glycolipids via CD1d.
- The interaction between NKT cell receptors (NKTCR) and glycolipids like α-galactosylceramide (α-GalCer) is more flexible than previously understood.
Purpose of the Study:
- To analyze the structure-function relationship of novel 6''-OH analogs of α-GalCer.
- To identify analogs with enhanced antitumor properties and understand their interaction with NKTCR.
Main Methods:
- Synthesis and structural analysis of novel α-GalCer analogs.
- Evaluation of glycolipid interactions with NKTCR.
- Assessment of antitumor activity and Th1 polarization in vivo.
Main Results:
- A novel carbamate analog, α-GalCer-6''-(pyridin-4-yl)carbamate, demonstrated potent antitumor characteristics.
- This analog formed unique interactions with the NKTCR.
- The novel interaction led to high Th1 polarization and superior antitumor responses.
Conclusions:
- Adding aromatic moieties to the 6''-OH position of α-GalCer enhances antitumor properties.
- Judicious linker selection can create potent Th1-polarizing glycolipids by improving CD1d or NKTCR binding.
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

